Company news

Dimerix Limited news in 2020

Dimerix Limited's news releases, calls and decks from 2020, newest first.

View company

Second Study to Include DMX-200 in COVID-19 Patients

November 29, 2020

ARDS in COVID-19 Patients Protocol Published

November 8, 2020

Positive Additional Data to Support DMX-200 Development

October 26, 2020

Receipt of R&D Tax Incentive

October 20, 2020

DMX-700 Data Demonstrates Effect on Key COPD Receptors

October 6, 2020

Positive Top-Line Results in DKD Phase 2 Clinical Study

September 13, 2020

Dimerix Awarded $1 Million MRFF Funding

September 2, 2020

Positive Top-Line Results in FSGS Phase 2a Clinical Study

July 28, 2020

Last Patient Completes Dosing in DKD Phase 2 Clinical Study

July 23, 2020

Dimerix Completes $5.8m Placement

June 22, 2020

Last Patient Completes Dosing in FSGS Phase 2 Clinical Study

June 16, 2020

Global REMAP-CAP Platform Trial Protocol To Include DMX-200

June 3, 2020

R&D Tax Incentive Facility

April 2, 2020

DMX-200 Treatment Continued Under TGA Special Access Scheme

March 2, 2020

Half Yearly Report and Accounts

February 18, 2020

Quarterly Commentary & Appendix 4C

January 20, 2020

DMX-200 Clinical Trial Update

January 6, 2020

Decks in 2020